glyburide has been researched along with Focal Neurologic Deficits in 2 studies
Glyburide: An antidiabetic sulfonylurea derivative with actions like those of chlorpropamide
glyburide : An N-sulfonylurea that is acetohexamide in which the acetyl group is replaced by a 2-(5-chloro-2-methoxybenzamido)ethyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beltrand, J | 1 |
| Elie, C | 1 |
| Busiah, K | 1 |
| Fournier, E | 1 |
| Boddaert, N | 1 |
| Bahi-Buisson, N | 1 |
| Vera, M | 1 |
| Bui-Quoc, E | 1 |
| Ingster-Moati, I | 1 |
| Berdugo, M | 1 |
| Simon, A | 1 |
| Gozalo, C | 1 |
| Djerada, Z | 1 |
| Flechtner, I | 1 |
| Treluyer, JM | 1 |
| Scharfmann, R | 1 |
| Cavé, H | 1 |
| Vaivre-Douret, L | 1 |
| Polak, M | 1 |
| De Vigan, C | 1 |
| Delporte, MP | 1 |
| Thomas, M | 1 |
| Perrault, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Sulfonylureas in Neonatal Diabetes Mellitus With Mutations of 2 Type of Subunits Kir6.2 and SUR1 of the Pancreatic Beta-cell ATP-sensitive K+ Channel.[NCT00610038] | Phase 2 | 19 participants (Actual) | Interventional | 2006-07-31 | Completed | ||
| Impact of Timing of Initiation of Sulphonylurea Therapy on Neurodevelopmental Outcomes in Individuals With Intermediate Developmental Delay, Epilepsy and Neonatal Diabetes (iDEND) Syndrome Due to the V59M Mutation in the KCNJ11 Gene[NCT05751525] | 21 participants (Anticipated) | Observational | 2016-07-01 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for glyburide and Focal Neurologic Deficits
| Article | Year |
|---|---|
Sulfonylurea Therapy Benefits Neurological and Psychomotor Functions in Patients With Neonatal Diabetes Owing to Potassium Channel Mutations.
Topics: Administration, Oral; Adolescent; Brain; Child; Child, Preschool; Diabetes Mellitus; Drug Substituti | 2015 |
Sulfonylurea Therapy Benefits Neurological and Psychomotor Functions in Patients With Neonatal Diabetes Owing to Potassium Channel Mutations.
Topics: Administration, Oral; Adolescent; Brain; Child; Child, Preschool; Diabetes Mellitus; Drug Substituti | 2015 |
Sulfonylurea Therapy Benefits Neurological and Psychomotor Functions in Patients With Neonatal Diabetes Owing to Potassium Channel Mutations.
Topics: Administration, Oral; Adolescent; Brain; Child; Child, Preschool; Diabetes Mellitus; Drug Substituti | 2015 |
Sulfonylurea Therapy Benefits Neurological and Psychomotor Functions in Patients With Neonatal Diabetes Owing to Potassium Channel Mutations.
Topics: Administration, Oral; Adolescent; Brain; Child; Child, Preschool; Diabetes Mellitus; Drug Substituti | 2015 |
1 other study available for glyburide and Focal Neurologic Deficits
| Article | Year |
|---|---|
[Hypoglycemic complications of oral drug therapy of diabetes mellitus. 21 cases].
Topics: Age Factors; Aged; Diabetes Mellitus; Diabetic Coma; Drug Interactions; Female; Gliclazide; Glyburid | 1976 |